Delivery Order SPE2DB20D2014-SPE2DB25FC59A
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,867.58 to AmerisourceBergen Drug Corp for the supply of Lidocaine 2% Viscous Solution in 100ml quantities. This contract, awarded on July 16, 2025, with an ultimate completion date of July 17, 2025, represents a firm fixed-price procurement with no set-aside designation. The award was competitively executed and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Lidocaine HCL 2% 200 mg/10 mL vials totaling $3,408.68 with a completion date of August 13, 2025. This is a firm fixed-price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,437.99 to AmerisourceBergen Drug Corp for Lidocaine HCL 1% vials (10 mL) on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract utilizes firm fixed pricing with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,376.18 to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Lidocaine HCL 1% 50 mg/5 mL vials (5 mL quantity). The award is firm fixed price with no set-aside designation, reflecting a competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate office location. This delivery order is issued under...
- The Defense Department, through its Medical Supply Chain division, awarded a delivery order valued at $1,712.10 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lidocaine HCL in 50ML quantities (25 units). The contract employs firm fixed pricing with no set-aside designation, indicating competitive award based on open competition. Performance will be executed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 2% Viscous Solution 100ML under a firm fixed-price contract valued at $6,361.57. The contract was awarded on June 25, 2025, with an ultimate completion date of June 26, 2025, and represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,903.04 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Lidocaine HCL 1% 50 mg/5 ml vials (5 ml). This firm fixed-price delivery order, which represents a non-set-aside competitive award, is scheduled for completion by July 28, 2025, with performance based in Conshohocken, Pennsylvania. The contract leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $7,809.06 to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 50ML (25 units) with an ultimate completion date of September 29, 2025. This competitive award, issued on September 2, 2025, carries firm fixed pricing and involves no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, which is also the headquarters location of AmerisourceBergen Drug Corp, a...
- AmerisourceBergen Drug Corp was awarded a delivery order for Lidocaine HCL 50ML (25 units) valued at $1,360.90 under a firm fixed price contract with the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The award, issued on August 13, 2025, with an ultimate completion date of August 13, 2025, represents a non-set-aside competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Lidocaine HCL 2% (200 mg/10 mL vials) with a ceiling value of $6,974.20. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of September 15, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. No set-aside designation was utilized...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC59ADelivery Order
The Defense Logistics Agency awarded a $2,030.80 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Lidocaine 2% Viscous in 15 ML cup unit dose format. This non-set-aside, firm fixed price contract is scheduled for completion by July 30, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. This lidocaine order fulfills immediate medical supply needs for federal healthcare operations while operating within the framework of the larger prime vendor contract designed to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 7/29/25 |